Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-021395
Filing Date
2018-03-23
Accepted
2018-03-23 16:18:27
Documents
1
Period of Report
2018-03-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 17132
  Complete submission text file 0001209191-18-021395.txt   18804
Mailing Address 950 WINTER STREET WALTHAM MA 02451
Business Address 950 WINTER STREET WALTHAM MA 02451 (858) 909-0749
Eloxx Pharmaceuticals, Inc. (Issuer) CIK: 0001035354 (see all company filings)

EIN.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address C/O ARNO THERAPEUTICS, INC. 200 ROUTE 31 NORTH, SUITE 104 FLEMINGTON NJ 08822
Business Address
Kariv Tomer (Reporting) CIK: 0001568077 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31326 | Film No.: 18710316